MacPherson Edward Clouston 4
4 · MIRA PHARMACEUTICALS, INC. · Filed Jun 15, 2026
Research Summary
AI-generated summary of this filing
MIRA Director MacPherson Receives 50,000 Stock Options
What Happened Edward Clouston MacPherson, a director of Mira Pharmaceuticals, was granted 50,000 stock options on June 12, 2026. The options were issued as an award (derivative grant) under the company’s 2022 Omnibus Incentive Plan. The reported exercise price is $0.94 per share; the Form 4 shows an acquisition value of $0 because this is an option grant, not a cash purchase or sale.
Key Details
- Transaction date: June 12, 2026; Form 4 filed June 15, 2026.
- Grant: 50,000 stock options, exercise price $0.94 each (equal to MIRA’s closing price on 6/12/2026 per the filing).
- Vesting: 50% vests at the six-month anniversary of the grant; remaining 50% vests at the 12‑month anniversary.
- Post-transaction holdings: Not specified in the provided excerpt of the filing.
- Filing timeliness: Form shows filing on 6/15/2026 for a 6/12/2026 grant; no explicit late-filing flag provided in the summary.
Context
- This was a grant of options (award), not an exercise or sale. The options give the holder the right to buy shares at $0.94 each once vested; exercising would require payment of the strike price (50,000 × $0.94 = $47,000) and is a separate action.
- Option grants to directors are commonly part of compensation and do not by themselves indicate buying or selling sentiment.
Insider Transaction Report
Form 4
MacPherson Edward Clouston
Director
Transactions
- Award
Stock Options (right to buy)
[F1][F2][F3]2026-06-12+50,000→ 50,000 totalExercise: $0.94Exp: 2036-06-12→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on June 12, 2026.
- [F2]The stock options were issued to the Reporting Person on June 12, 2026 (the "Grant Date"), pursuant to the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"). 50% of the options vest on the six-month anniversary of the grant date, and the remaining 50% vest on the one-year anniversary of the Grant Date.
- [F3]Represents 50,000 stock options that were issued to the Reporting Person on June 12, 2026, that vest in equal halves on the six and 12 month anniversaries of the grant date, pursuant to a grant under the Plan at an exercise price of $0.94 each.
Signature
/s/ Edward MacPherson|2026-06-15